Muscle Pharm Corporation (MSLPQ)

[Odessa99]

Regarding the potential $1 billion valuation for MSLP, here's something I posted here (in sept of 2013) - below in blue...

"Hypothesis: Muscle Pharm could be valued at $1 billion within the next 24 months. How can such a seemingly absurd statement be made? Because I found a number of NASDAQ and NYSE companies with quarterly revenue in the neighborhood of $10 - $35 million with a market cap of between $800 million and $1.1 billion.

Some examples that I've found are NASDAQ:HALO, NASDAQ:PFPT, NYSE:GIMO, NASDAQ:ELGX, NASDAQ:HSTM, NYSE:STAG, and NASDAQ:EPZM.

some key stats
HALO: (market cap of $1 billion; booking losses every quarter; accumulated deficit $340 million)
PFPT: (market cap of $1 billion; booking losses every quarter; accumulated deficit $190 million)
GIMO: (market cap of $1.1 billion; accumulated deficit $22 million)
ELGX: (market cap of $1 billion; only recently turned the corner into profitability; accumulated deficit of $200 million)
HSTM: (market cap of $950 million; accumulated deficit of $21 million)
STAG: (market cap $870 million; booking losses nearly every quarter; accumulated deficit of $90 million)
EPZM: (market cap $920 million; accumulated deficit of $62 million)

What most of these companies have in common with Muscle Pharm is the high rate of sales growth over the past few years, as well as their long history of net losses while growing sales. Some have reported profits in the more recently completed quarters. For those unfamiliar with the term 'accumulated deficit', it refers to the cumulative losses since inception. Companies with a solid track record of positive earnings would have a 'retained earnings' balance, rather than an 'accumulated deficit' balance.

I feel the above examples make it at least plausible that Muscle Pharm could achieve a market cap of $1 billion within the next 24 months. As always, simply my opinion."

link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92070131

Vega reeled in net sales of $100 million during the past 12 months and grew at a 30 percent rate on a constant currency basis, WhiteWave officials said. Vega is expected to boost WhiteWave's adjusted earnings per share next year by 6 cents.

Describing Vega as in the "early stages of its growth cycle," WhiteWave officials said the brand is positioned to capitalize in the plant-based foods segment and the $8.6 billion nutritional powders, bars and ready-to-drink beverages.

That's the equivalent of $MSLP being a 1.1B company. Holy smokes Batman

MSLP